Recnac

Survival of Pancreatic Cancer Patients is Doubled Through Nano-knife Ablation

Dr. Robert C. G. Martin II, MD, PhD., Director of Surgical Oncology at the University of Louisville, Kentucky, and colleagues reported that the median survival of pancreatic cancer patients is doubled through nano-knife ablation. The research team explained that through proper and accurate usage of nano-knife ablation, the median overall survival is approximately 2 years in patients with advanced-stage pancreatic cancer. They added that with this study, nano-knife ablation is now another treatment option for patients with stage 3 pancreatic cancer. Previously, the treatment options were a combination of both chemotherapy and radiotherapy or chemotherapy alone.

This nano-knife ablation destroys cell membranes of diseased tissues and leaves the healthy tissues through the delivery of direct current microsecond pulses. The 6 surgical centers involved in this study include the Cancer Treatment Centers of America in Atlanta, the Swedish Medical Center in Denver, the University of Louisville, the Piedmont Hospital in Atlanta, the Henry Ford Hospital in Detroit, and the Cleveland Clinic. This study was conducted on 200 patients diagnosed with advanced-stage pancreatic cancer. They were given chemoradiation, chemotherapy, or both as suggested by the institution protocol. After one month of treatment, these patients were staged again with serum tumor markers and a triple-phase CT scan. Nano-knife ablation was done in selected patients. Selection criteria include assessment of patient’s pre-resection margin during operation, patient’s comorbidities, and patient’s previous therapy.

Sixty-three percent of patients who received nano-knife ablation alone had tumors in the pancreatic head while 75% of patients who received both nano-knife ablation and resection had tumors in the pancreatic neck or body. Patients who received both nano-knife ablation and resection had a median overall survival of 23 months while patients who received nano-knife ablation alone had a median overall survival of 18 months. The most common unwanted side effects were gastrointestinal complaints. Dr. Jeffrey A. Drebin, MD, PhD, from the Department of Surgery, University of Pennsylvania Health System, Pennsylvania, congratulates the research team for studying the nano-knife ablation technique as an option for pancreatic cancer treatment. He felt that the research team has achieved excellent results through this study. Dr. Keith D. Lillemoe, MD, from the Department of Surgery at the Massachusetts General Hospital, Boston, and Editor-in-Chief of Annals of Surgery, commented that these study results requires more confirmation. A study comparing radiation therapy, nano-knife ablation, and chemotherapy with radiotherapy and chemotherapy is needed to further confirm the findings of this study.

Reference 1

Reference 2

Image

hengjing0313

hengjing0313

Top Posts | Research

Mediterranean diet

Mediterranean Dietary Lifestyle May Prevent Breast Cancer

Dr. Miguel Á. Martínez-González, MD, from the Instituto de Salud Carlos III in Madrid, and colleagues reported that breast cancer may be prevented by adopting a Mediterranean diet lifestyle that is known to be protective against cardiovascular diseases. The Mediterranean diet c ... ...

Immunological Cancer Therapy Takes Precedence

The human body is very tough. It can take a lot of abuse and still manage to function. However, just like a well-built machine, it is the internals of the human body that matter more than what is outside. So if something attacks from within, there is a chance that it may be enough to take over the ...

Sitting Linked to Increased Risk for Cancer in Women

According to a study conducted by the American Cancer Society, sitting too much can raise cancer risk in females. The study shows that women who spend 6 hours or more of their time sitting have increased cancer risk by 10% in comparison to the women who spend 3 hours of their time per day sitting.T ...

Light to Moderate Alcohol Intake Increases Cancer Risk

Dr. Edward L. Giovannucci, MD, ScD, Professor of Nutrition, Harvard T. H. Chan School of Public Health, Boston, and colleagues reported that light to moderate alcohol intake increases cancer risk. The research team urged for updated health precautions on alcohol intake. The research team explained ...

Coffee Might Lower the Recurrence Risk of Colon Cancer

Dr. Charles Fuchs, MD, MPH, from the University of Dana-Farber Cancer Institute in Boston and colleagues reported that coffee might lower the recurrence risk of colon cancer. Despite their findings, the research team warned that these findings are not evidence of causation and are only associations ...